Amplify Weight Loss Drug ... (THNR)
AMEX: THNR
· Real-Time Price · USD
23.26
0.32 (1.39%)
At close: Aug 18, 2025, 2:20 PM
THNR Holdings List
As of Aug 12, 2025
The Amplify Weight Loss Drug & Treatment ETF is an equity ETF with a total of 22 individual holdings.
The top holdings are Eli Lilly and Company at 10.33%, Novo Nordisk A/S at 8.12%, Regeneron Pharmaceuticals at 7.35%, Amgen at 6.75%, and Gilead Sciences at 5.67%.
22
64.79%
Equity
3.09M
22.61
0.5900%
Sector Allocation
| Rank | Symbol | Name | Price | % Change | Shares | % Weight |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and C... | 698.85 | -0.34% | 666 | 10.33% |
| 2 | NVO | Novo Nordisk A/... | 53.80 | +2.64% | 6.67K | 8.12% |
| 3 | REGN | Regeneron Pharm... | 573.95 | -1.11% | 551 | 7.35% |
| 4 | AMGN | Amgen Inc. | 292.57 | -1.32% | 969 | 6.75% |
| 5 | GILD | Gilead Sciences... | 117.99 | -0.32% | 1.93K | 5.67% |
| 6 | 4519.T | Chugai pharmace... | n/a | n/a | 5.5K | 5.53% |
| 7 | ABBV | AbbVie Inc. | 206.48 | -0.1% | 1.12K | 5.45% |
| 8 | PFE | Pfizer Inc. | 25.06 | -0.32% | 8.7K | 5.22% |
| 9 | AZN | AstraZeneca PLC | 79.14 | -0.04% | 2.88K | 5.21% |
| 10 | MRK | Merck & Co., In... | 84.22 | +0.01% | 2.64K | 5.16% |
| 11 | 1093.HK | Cspc pharmaceut... | n/a | n/a | 150K | 4.83% |
| 12 | ROG.SW | Roche holding a... | n/a | n/a | 640 | 4.74% |
| 13 | 4507.T | Shionogi & co l... | n/a | n/a | 9.9K | 4.31% |
| 14 | 1801.HK | Innovent biolog... | n/a | n/a | 14.5K | 4.06% |
| 15 | HIMS | Hims & Hers Hea... | 45.11 | -1.98% | 3.05K | 3.73% |
| 16 | Cash&Other | Cash & other | n/a | n/a | 125.75K | 3.07% |
| 17 | VKTX | Viking Therapeu... | 42.18 | +5.37% | 2.96K | 2.76% |
| 18 | ZEAL.CO | Zealand pharma ... | n/a | n/a | 1.71K | 2.15% |
| 19 | CRNX | Crinetics Pharm... | 29.72 | -3.26% | 2.35K | 1.57% |
| 20 | 3933.HK | United laborato... | n/a | n/a | 18K | 0.86% |
| 21 | 128940.KS | Hanmi pharm co ... | n/a | n/a | 167 | 0.82% |
| 22 | AGPXX | Invesco governm... | n/a | n/a | 22.04K | 0.54% |